Has Sara Durkin, PA received payments from drug or device companies?

Yes. Drug and device makers reported $28,451 in general payments to Sara Durkin, PA across 378 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sara Durkin, PA did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sara Durkin, PA come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sara Durkin, PA

Physician Assistant · Saint Petersburg, FLNPI 1396029823

Payments from drug & device makers

$28,451in general payments, 2019–2025

Across 378 payments — averaging $75.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Exelixis Inc.$10K
Eli Lilly$3K
AstraZeneca$2K
Eisai Inc.$1K
Regeneron Healthcare Solutions, Inc.$1K
Daiichi Sankyo Inc.$902
plus $10K from 54 others

What the payments were for

Consulting fees$4,59016%
Speaking & faculty fees$4,25315%
Travel & lodging$4,66716%
Food & beverage$14,84152%
Education$1000%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Exelixis Inc.	32	$10,416
Eli Lilly	1	$3,300
AstraZeneca(2 entities)	30	$1,675
Eisai Inc.	19	$1,154
Regeneron Healthcare Solutions, Inc.	6	$1,024
Daiichi Sankyo Inc.	17	$902
Lilly USA, LLC	24	$806
Novartis	40	$727
Jazz Pharmaceuticals Inc.	6	$699
E.r. Squibb & Sons, L.L.C.	8	$691
Johnson & Johnson(2 entities)	18	$547
Pharmacyclics LLC, An Abbvie Company	7	$520
Genentech USA, Inc.	8	$499
Blueprint Medicines Corporation	5	$455
GSK	6	$406
Rigel Pharmaceuticals, Inc.	7	$355
Gilead(2 entities)	12	$338
Seagen Inc.	14	$303
AbbVie	4	$280
Takeda Pharmaceuticals U.S.A., Inc.	8	$277
Servier Pharmaceuticals LLC	2	$250
Incyte Corporation	6	$226
Astellas Pharma US Inc	6	$211
Pfizer	11	$207
Dendreon Pharmaceuticals LLC	2	$174
Bristol Myers Squibb	9	$168
Stemline Therapeutics Inc.	2	$152
CTI Biopharma Corp.	2	$138
Genmab U.S., Inc.	1	$125
AVEO Pharmaceuticals, Inc.	2	$123
Sanofi	6	$115
Beigene USA, Inc.	2	$106
Merck	4	$87
Springworks Therapeutics, Inc.	3	$87
Sobi, Inc	4	$78
Amgen	4	$78
EMD Serono, Inc.	3	$68
Bayer	4	$63
Fennec Pharmaceuticals, Inc.	2	$50
Array Biopharma Inc	3	$49
Boehringer Ingelheim	2	$41
Myovant Sciences Inc.	2	$39
Pharmacosmos Therapeutics Inc.	2	$38
Global Blood Therapeutics, Inc.	2	$37
Sumitomo Pharma America, Inc.	2	$36
Puma Biotechnology, Inc.	2	$36
Myriad Genetic Laboratories, Inc.	2	$32
Tersera Therapeutics LLC	1	$31
Getinge USA Sales, LLC	1	$30
G1 Therapeutics, Inc.	2	$29
CSL Behring	1	$21
TG Therapeutics, Inc.	1	$19
Caris MPI, Inc.	1	$19
Taiho Oncology, Inc.	1	$18
GE HealthCare	1	$17
Karyopharm Therapeutics Inc.	1	$17
Progenics Pharmaceuticals, Inc.	1	$16
EUSA Pharma (US) LLC	1	$15
Alnylam Pharmaceuticals Inc.	1	$14
Apellis Pharmaceuticals, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,451 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida →

Medicare billing

Part B allowed, 2024

$5,521

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Famotidine	22	$394
Levothyroxine Sodium	16	$60

Paid to pharmacies, not to this prescriber.

Other physician assistant in Saint Petersburg

Richard MarshallPort Orange$988K
Audrey BeckerSt Augustine$689K
Kevin WilliamsTampa$647K
Brian BonomoLecanto$559K
Melissa SingletonOcala$482K
Reeli ReinuMaitland$427K
Jeanelle KingMiami$424K
Risha BellomoOrlando$397K
Jason BergerClearwater$344K
Ashley MillerGainesville$328K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →